相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
Shuai Xia et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity
Ji Wang et al.
SCIENCE (2020)
Inhibition of SARS-CoV-2 (previously 2019-nCoV) infection by a highly potent pan-coronavirus fusion inhibitor targeting its spike protein that harbors a high capacity to mediate membrane fusion
Shuai Xia et al.
CELL RESEARCH (2020)
Don't rush to deploy COVID-19 vaccines and drugs
Shibo Jiang
NATURE (2020)
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding
Tyler N. Starr et al.
CELL (2020)
A novel receptor-binding domain (RBD)-based mRNA vaccine against SARS-CoV-2
Wanbo Tai et al.
CELL RESEARCH (2020)
Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy
Hongjing Gu et al.
SCIENCE (2020)
Broad neutralization of SARS-related viruses by human monoclonal antibodies
Anna Z. Wec et al.
SCIENCE (2020)
Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study
Barnaby E. Young et al.
LANCET (2020)
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
Bina Choi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
Zezhong Liu et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin
Shuai Xia et al.
SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)
A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
Shuai Xia et al.
SCIENCE ADVANCES (2019)
Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines
Lanying Du et al.
NATURE COMMUNICATIONS (2016)
分享论文
